Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma

S Lee; Y H Park; K H Kim; E Y Cho; Y C Ahn; K Kim; Y-M Shim; J S Ahn; K Park; Y-H Im

首页> 外文期刊>British Journal of Cancer >Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma

【24h】

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma

机译：胸苷合酶，胸苷磷酸化酶和切除修复交叉互补组1表达作为卡培他滨联合顺铂化疗作为晚期食管鳞癌一线治疗的预测指标

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:Our purpose was to evaluate thymidine synthase (TS), thymidine phosphorylase (TP), and excision repair cross-complementation group 1 (ERCC1) expression as biomarkers for capecitabine and cisplatin (XP) combination chemotherapy in patients with metastatic oesophageal squamous cell cancer.

机译：背景：我们的目的是评估转移性食管鳞状细胞癌患者胸苷合酶（TS），胸苷磷酸化酶（TP）和切除修复交叉互补组1（ERCC1）的表达，作为卡培他滨和顺铂（XP）联合化疗的生物标志物。。

著录项

来源
《British Journal of Cancer》 |2010年第6期|共7页
作者
S Lee; Y H Park; K H Kim; E Y Cho; Y C Ahn; K Kim; Y-M Shim; J S Ahn; K Park; Y-H Im;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Expression of Thymidylate Synthase and Thymidine Phosphorylase as Prognostic Markers in Advanced Esophageal Squamous Cell Carcinoma [J] . Arbabi Bidgoli, Sepideh, Minaee, International Journal of Pharmacology . 2005,第2期

机译：胸苷酸合酶和胸苷磷酸化酶的表达作为晚期食管鳞状细胞癌预后的标志物
2. Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel [J] . Jing Gao, Ming Lu, Jing-wei Yu, BMC Cancer . 2011,第1期

机译：胸苷磷酸化酶/β-微管蛋白III的表达预测接受一线卡培他滨加紫杉醇的中国晚期胃癌患者的反应
3. Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells. [J] . Jen-Chung Ko, Yu-Ching Huang, Huang-Jen Chen, Basic & clinical pharmacology & toxicology. . 2013,第1期

机译：二甲双胍通过下调胸苷磷酸化酶和切除修复交叉互补1在非小细胞肺癌细胞中的表达诱导细胞毒性。
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Thymidine synthase thymidine phosphorylase and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma [O] . S Lee, Y H Park, K H Kim, 2010

机译：胸苷合酶胸苷磷酸化酶和切除修复交叉互补1组表达作为卡培他滨联合顺铂化疗作为晚期食管鳞癌一线治疗的预测指标
7. Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma [O] . Lee, S, Park, Y H, Kim, K H, 2010

机译：胸苷合酶，胸苷磷酸化酶和切除修复交叉互补1组表达作为卡培他滨联合顺铂化疗作为晚期食管鳞癌一线治疗的预测指标

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅